Drug Recall: Little Moon Essentials Magical Muscle Oil due to CGMP Deviations
Little Moon Essentials is recalling Magical Muscle Oil due to manufacturing practice deviations. The recall affects 1,654 glass jars distributed nationwide in the USA and Canada.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II voluntary recall with no reported illnesses or injuries. CGMP deviations represent manufacturing practice non-compliance rather than an identified specific hazard, making this a precautionary recall.
Plain-English summary
Little Moon Essentials, LLC is recalling Magical Muscle Oil (containing Camphor 1.95% and Menthol 3.75%) due to Current Good Manufacturing Practice (CGMP) deviations. The affected products include 2 FL OZ (59 mL) and 4 FL OZ (118 mL) glass jars distributed across multiple lot codes.
Approximately 1,654 glass jars are subject to this recall, which affects consumers nationwide in the United States and Ontario, Canada. The recall was voluntarily initiated by the manufacturer on June 20, 2024, and reported to the FDA on July 10, 2024. The products were distributed through 2 retailers.
The recalled product
- Product
- Little Moon Essentials, Magical Muscle Oil, (Camphor 1.95%, Menthol 3.75%) packaged as: a) 2 FL OZ (59ML) glass jar, UPC Code 6 73673 88202 2, NDC 70722-246-02; b) 4 FL OZ (118ML) jar, UPC Code 6 73673 88233 6, NDC 70722-246-04; Little Moon Essentials LLC Dania Beach, Fl 33004
- Manufacturer
- Little Moon Essentials LLC
- Category
- Drug — Topical Oil
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- lot code No expiration date on product: a) 325240
- 320260
- 329011
- 324021
- 328221
- 421110
- 422120
- 423120
- 421220
- 426220
- 428220
- b) 329230
- 328140
- 320290
- 328011.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27